Overview

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Status:
Withdrawn
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Catheter directed retrograde venous infusion of gemcitabine/lipiodol into pancreatic tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Treatments:
Ethiodized Oil
Gemcitabine